Drugs / Rocurium
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00474617 Background | Dec 2005 → Oct 2006 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rocurium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00474617 ↗ |
| Route | Intravenous | “Participants to receive an intravenous (IV) single bolus dose of 0.6 mg.kg-1 rocuronium.” NCT00474617 ↗ |